Reliance Industries, Cancer genome sequencing
Strand Life Sciences, a Reliance subsidiary, Launches Pioneering Blood-based Test for Early Detection of Multiple Cancers
Leading genomics and bioinformatics company Strand Life Sciences, a subsidiary of Reliance Industries Limited, has launched a novel blood-based test for early detection of multiple cancers. Called CancerSpot,
Reliance Industries Ltd. 500325 shares advanced 1.09% to 1,323.35 Indian rupees Tuesday, on what proved to be an all-around ...
Central government's decision to abolish windfall tax may help the oil companies like Reliance and ONGC, market has already ...
Indian shares closed higher on Monday, led by gains in heavyweights such as Reliance Industries, as the recent decline ...
Reliance Industries Ltd is quoting at Rs 1323.95, up 1.13% on the day as on 12:49 IST on the NSE. The stock is up 9.41% in last one year as compared to a 18.09% gain in NIFTY and a 25.14% gain in the ...
Reliance Industries ( Mumbai International) has taken delivery of its first E175, VT-JMR (msn 17000976), ch-aviation research ...
Shares of Reliance Industries Ltd. 500325 inched up 0.60% to 1,295.55 Indian rupees Tuesday, on what proved to be an ...
Digital Connexion, formerly known as BAM Digital Realty, currently has two data centers, located in the country’s financial ...
By Bharath Rajeswaran (Reuters) -Indian shares closed higher for a third straight session on Tuesday, led by HDFC Bank and Reliance Industries due to cheaper valuations after the benchmarks slipped ...
Oil and Natural Gas Corporation , Oil India, Reliance Industries among othes saw their share price rise up to 3% durng the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback